CellDrop Biosciences
PrivateLast Round
Grant
Oct 27, 2023
Total Funding Raised
$1.73M
Company Overview
CellDrop Biosciences is a biotechnology company that develops hydrogel-based encapsulation platforms for scalable, allogeneic stem cell therapies and point-of-care diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellDrop Biosciences Comparables
Compare CellDrop Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Equine Amnio Solutions, LLC | 86% | |
| eQcell Inc. | 82% | |
| EQGen Biomedical | 81% |
CellDrop Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 27, 2023 | ||||
| Seed | Oct 26, 2023 | ||||
| Grant | Feb 3, 2021 |
CellDrop Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breakthrough 307 | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 418% MoM, reaching 803.
- May 4, 2025
Monthly visitors increased 705% MoM.
Recent news
Latest coverage and updates
- expands_facilitiesJul 2, 2026
CellDrop Biosciences expanded facilities to Laramie, Wyoming, United States, Northern America, Americas on Jul 2nd '26.
CellDrop Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CellDrop Biosciences's valuation, stock price, and market status.
Is CellDrop Biosciences a public or private company?
CellDrop Biosciences is a private company.
What is the current stock price of CellDrop Biosciences?
CellDrop Biosciences is a private company with no public stock price. Caplight tracks CellDrop Biosciences's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CellDrop Biosciences worth (valuation)?
Valuation information for CellDrop Biosciences is not publicly available.
Can I buy CellDrop Biosciences stock?
CellDrop Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CellDrop Biosciences's last funding round?
CellDrop Biosciences's most recent funding round was Grant on October 27, 2023.
Who are the main investors in CellDrop Biosciences?
Key investors in CellDrop Biosciences include Breakthrough 307, National Science Foundation.
Will CellDrop Biosciences IPO soon?
No public IPO plans have been announced for CellDrop Biosciences.
How can I track CellDrop Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CellDrop Biosciences's secondary market activity and sign up for updates.